| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9027 |
| Human Intestinal Absorption | HIA+ | 0.9866 |
| Caco-2 Permeability | Caco2+ | 0.5465 |
| P-glycoprotein Substrate | Non-substrate | 0.8436 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8865 |
| Non-inhibitor | 0.9646 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8883 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5512 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6512 |
| CYP450 2D6 Substrate | Non-substrate | 0.8995 |
| CYP450 3A4 Substrate | Non-substrate | 0.7052 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6289 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9812 |
| Non-inhibitor | 0.8329 |
| AMES Toxicity | Non AMES toxic | 0.7762 |
| Carcinogens | Non-carcinogens | 0.8819 |
| Fish Toxicity | Low FHMT | 0.7212 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5564 |
| Honey Bee Toxicity | Low HBT | 0.7890 |
| Biodegradation | Not ready biodegradable | 0.9947 |
| Acute Oral Toxicity | IV | 0.6259 |
| Carcinogenicity (Three-class) | Non-required | 0.5231 |